European Equities Traded in the US as American Depositary Receipts Climb in Monday Trading

MT Newswires Live
Yesterday

European equities traded in the US as American depositary receipts were tracking sharply higher late Monday morning, rising 2.55% to 1,721.67 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by lenders Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria (BBVA), which rose 7% and 5.1%, respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and internet advertising firm Criteo (CRTO), which were up 2.8% and 2.7%, respectively.

The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and medical device maker EDAP TMS (EDAP), which fell 5.5% and 1.9%, respectively. They were followed by oil and gas company Eni (E) and pharmaceutical company Ascendis Pharma (ASND), which were down 1.4% and 0.3%, respectively.

The gainers from the UK were led by cruise line operator Carnival (CUK) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which advanced 8.1% and 7.6%, respectively. They were followed by mining company BHP Group (BHP) and lender HSBC (HSBC), which increased 4.9% and 4.8%, respectively.

The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN), which dropped 5.9%, followed by oil and gas company BP (BP) and biopharmaceutical company Bicycle Therapeutics (BCYC), which lost 2.5% and 0.3%, respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10